| MolName | 2-hydroxy-N-[(Z)-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylideneamino]benzamide |
| MolecularFormula | C20H19N5O4 |
| Smiles | Oc(cccc1)c1C(N/N=C\C1=C(N2CCOCC2)N=C(C=CC=C2)N2C1=O)=O |
| InChI | InChI=1S/C20H19N5O4/c26-16-6-2-1-5-14(16)19(27)23-21-13-15-18(24-9-11-29-12-10-24)22-17-7-3-4-8-25(17)20(15)28/h1-8,13,26H,9-12H2,(H,23,27) |
| InChIK | RCHFEOPVRNUUQJ-UHFFFAOYSA-N |
| TotalMolweight | 393.402 |
| Molweight | 393.402 |
| MonoisotopicMass | 393.143705 |
| CLogP | 0.3208 |
| CLogS | -3.424 |
| H Acceptors | 9 |
| H Donors | 2 |
| TotalSurfaceArea | 295.36 |
| Relative PSA | 0.30729 |
| PolarSurfaceArea | 106.83 |
| Druglikeness | 6.5869 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB; twice activated DB; acyl-hydrazone; imine/hydrazone of aldehyde |
| Shape Index | 0.48276 |
| Fragments | 1 |
| Non HAtoms | 29 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| Rotatable Bond | 4 |
| Rings Closures | 4 |
| Small Rings | 4 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 6 |
| Symmetricatoms | 2 |
| Amides | 1 |
| BasicNitrogens | 1 |
| StereoCon |
Click to Load Molecule:
1 - 2-hydroxy-N-[(Z)-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylideneamino]benzamide | 2 - 2-hydroxy-N-[(Z)-(2-morpholin-4-yl-4-oxopyrido[1,2-a]pyrimidin-3-yl)methylideneamino]benzamide